These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7001547)

  • 1. [Use of Ufudix ointment for the treatment of keratoacanthoma. I. Clinical evaluation of the results].
    Starzycki Z
    Przegl Dermatol; 1980; 67(4):469-74. PubMed ID: 7001547
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of keratoacanthoma with trichloroacetic acid].
    Lańcucki J; Samochocki Z
    Przegl Dermatol; 1982; 69(5-6):465-8. PubMed ID: 6764681
    [No Abstract]   [Full Text] [Related]  

  • 3. [The local treatment of the keratoacanthoma with 5-fluorouracil].
    Ebner H; Mischer P
    Hautarzt; 1975 Nov; 26(11):585-8. PubMed ID: 1205845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of keratoacanthoma with topical application of fluorouracil.
    Goette DK; Odom RB; Arrott JW; Diakon NC; Horn RT
    Arch Dermatol; 1982 May; 118(5):309-11. PubMed ID: 7082021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large keratoacanthomas in difficult locations treated with intralesional 5-fluorouracil.
    Parker CM; Hanke CW
    J Am Acad Dermatol; 1986 May; 14(5 Pt 1):770-7. PubMed ID: 3711381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of Efudix ointment for the treatment of keratoacanthoma. II. Histological observations during treatment].
    Starzycki Z
    Przegl Dermatol; 1980; 67(4):475-9. PubMed ID: 7433712
    [No Abstract]   [Full Text] [Related]  

  • 7. [Topical therapy of precancerous lesions and skin carcinomas using a 5-fluorouracil ointment].
    Uthida-Tanaka AM; Nakamura S; de Britto-Costa R; de Tavares Mello E
    Hospital (Rio J); 1969 Dec; 76(6):2207-20. PubMed ID: 5309543
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of keratoacanthoma with intralesional methotrexate injections].
    Richard MA; Gachon J; Choux R; Laurans R; Folchetti G; Grob JJ
    Ann Dermatol Venereol; 2000 Dec; 127(12):1097. PubMed ID: 11173689
    [No Abstract]   [Full Text] [Related]  

  • 9. [Topical cytostatic treatment of epitheliomas with a 5 per cent 5-fluorouracil ointment].
    Ebner H
    Z Haut Geschlechtskr; 1968 Sep; 43(18):757-62. PubMed ID: 5715906
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic trial with 5-fluorouracil ointment].
    Lopes CF; Armond S
    Hospital (Rio J); 1970 Apr; 77(4):1275-80. PubMed ID: 4939510
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of keratoacanthomas by local applications of the 5-fluorouracil (5-FU) ointment.
    Grupper C
    Dermatologica; 1970; 140():Suppl 1:127+. PubMed ID: 5471358
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of keratoacanthoma with topical fluorouracil.
    Goette DK
    Arch Dermatol; 1983 Nov; 119(11):951-3. PubMed ID: 6639118
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of interferon-alpha (IFN-alpha) in the treatment of keratoacanthoma].
    Somlai B; Holló P
    Hautarzt; 2000 Mar; 51(3):173-5. PubMed ID: 10789078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of podophyllin in the treatment of keratoacanthoma.
    Cipollaro VA
    Int J Dermatol; 1983 Sep; 22(7):436-40. PubMed ID: 6629612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
    Doss N; Reitamo S; Dubertret L; Fekete GL; Kamoun MR; Lahfa M; Ortonne JP
    Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imiquimod as neoadjuvant treatment for giant keratoacanthoma arising on a background of lupus vulgaris.
    Tsikeloudi M; Lallas A; Sidiropoulos T; Chasioti V; Lefaki I; Apalla Z
    Clin Exp Dermatol; 2014 Jan; 39(1):60-2. PubMed ID: 23773180
    [No Abstract]   [Full Text] [Related]  

  • 17. Aggressive giant keratoacanthoma of the face treated with intramuscular methotrexate and triamcinolone acetonide.
    Santoso-Pham JC; Shelley ED; Shelley WB
    Cutis; 1997 Jun; 59(6):329-32. PubMed ID: 9218892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of keratoacanthomas with intralesional fluorouracil.
    Odom RB; Goette DK
    Arch Dermatol; 1978 Dec; 114(12):1779-83. PubMed ID: 736584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of etretinate (Tegison; Tigason) in the management of keratoacanthoma.
    Cristofolini M; Piscioli F; Zumiani G; Scappini P
    J Am Acad Dermatol; 1985 Apr; 12(4):633-8. PubMed ID: 3989024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reaction to topical fluorouracil of secondary lymphedema.
    Grattan CE; Guerrier CJ
    Arch Dermatol; 1985 Dec; 121(12):1484. PubMed ID: 2933003
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.